J7645 HCPCS Level II code: Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
J7645 is the HCPCS code for “Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J7645Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Short description: Ipratropium bromide comp
HCPCS · United States
Medicare details
The indicators CMS publishes with J7645 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Drugs Administered through DME
- Added
- Jan 1, 2007
Where J7645 sits
- 1J codesDrugs administered other than orally
- 2Active code J7645Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J7645 mean?
J7645 is the HCPCS code for “Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J7645?
CMS lists J7645’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7645
All J codesJ7639Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligramJ7640Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 microgramsJ7641Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligramJ7642Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligramJ7643Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligramJ7644Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligramJ7647Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligramJ7648Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligramJ7649Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligramJ7650Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligramJ7657Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligramJ7658Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram